Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials
CREDENCE and PACIFIC-1 study data demonstrate potential power of AI-QCT ISCHEMIA
Source: dicardiology.com
Jamesp Earls News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jamesp Earls. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jamesp Earls Today - Breaking & Trending Today
Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve
FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery disease
Source: dicardiology.com
Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease
Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.
Source: dicardiology.com